Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus Ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines

Acta Virologica

Volumn 51, Issue 2, 2007, Pages 125-130

  Nam, J H ^a   Bang, H S ^b   Cho, H W ^c   Chung, Y H ^b  

^a The Catholic University of Korea   (South Korea)

^b Hanyang University   (South Korea)

^c Korea National Institute of Health   (South Korea)

Author keywords

Co stimulatory molecules B7.1, B7.2; Hepatitis B virus; Immune response; Japanese encephalitis virus; Vaccine

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA; HEPATITIS VACCINE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN PRM E; VIRUS VACCINE; CD86 PROTEIN, HUMAN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; JAPANESE ENCEPHALITIS VACCINE; PRM PROTEIN, FLAVIVIRUS; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS B VIRUS; IMMUNE RESPONSE; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; VACCINIA VIRUS; ANIMAL; BLOOD; CHO CELL; CRICETULUS; GENETICS; HAMSTER; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; METABOLISM;

HEPATITIS B VIRUS; JAPANESE ENCEPHALITIS VIRUS; MUS; VACCINIA VIRUS ANKARA;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD80; ANTIGENS, CD86; CHO CELLS; CRICETINAE; CRICETULUS; ENCEPHALITIS VIRUS, JAPANESE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED ICR; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 38449087010     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C (1993): B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79. (Pubitemid 23345240)
2. Boyer JD, Chattergoon M, Muthumani K, Kudchodkar S, Kim J, Bagarazzi M, Pavlakis G, Sekaly R, Weiner DB (2002): Next generation DNA vaccines for HIV-1. J. Liposome Res. 12, 137-142. (Pubitemid 34846965)
3. Brennan FR, Mikecz K, Buzas EI, Ragasa D, Cs-Szabo G, Negroiu G, Glant TT (1995): Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycaninduced arthritis. Clin. Exp. Immunol. 101, 414-421.
4. Cho HW, Kim JL, Ban SJ, Chung YJ, Nam JH, Lee YJ, Kim EJ, Wong HE, Chae SL (1995): Studies on the duration of immunity and reactogenicity following immunization with Japanese encephalitis vaccine (I). Rep. Natl. Inst. Health 32, 151-158.
5. Davis MM, Bjorkman PJ (1988): T-cell antigen receptor genes and T-cell activation. Nature 334, 395-399.
6. Fraser JD, Irving BA, Crabtree GR, Weiss A (1991): Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251, 313-316.
7. Frauwirth KA, Thompson CB (2002): Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 109, 295-299.
8. Kim JJ, Bagarazzi ML, Trivedi N, Hu Y, Kazahaya K, Wilson DM, Ciccarelli R, Chattergoon MA, Dang K, Mahalingam S, Chalian AA, Agadjanyan MG, Boyer JD, Wang B, Weiner DB (1997): Engineering of in vivo immune responses to DNA immunization via code livery of co-stimulatory molecule genes. Nat. Biotechnol. 15, 641-646. (Pubitemid 27291164)
9. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996): Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438. (Pubitemid 26162734)
10. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA (1995): Differential effects of anti-B7- 1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the non-obese diabetic mouse. J. Exp. Med. 181, 1145-1155.
11. Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A (1997): Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines. Vaccine 15, 1732-1736. (Pubitemid 27448533)
12. Nam JH, Wyatt LS, Chae SL, Cho HW, Park YK, Moss B (1999): Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes. Vaccine 17, 261-268.
13. Nam JH, Chae SL, Cho HW (2002): Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in swine. Microbiol. Immunol. 46, 23-28.
14. Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett TA, Sayegh MH (1996): Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J. Clin. Invest. 97, 833-838. (Pubitemid 26057103)
15. Santra S, Barouch DH, Jackson SS, Kuroda MJ, Schmitz JE, Lifton MA, Sharpe AH, Letvin NL (2000a): Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. J. Immunol. 165, 6791-6795. (Pubitemid 32001145)
16. Santra S, Barouch DH, Sharpe AH, Letvin NL (2000b): B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination. Eur. J. Immunol. 30, 2650-2659.
17. Sharpe AH (1996): Co-stimulatory signals and viral immunity. Sem. Virol. 7, 103-111.
18. Schwartz RH (1990): A cell culture model for T lymphocyte clona1 anergy. Science 248, 1349-1353.
19. Tsuji T, Hamajima K, Ishii N, Aoki I, Fukushima J, Xin KQ, Kawamoto S, Sasaki S, Matsunaga K, Ishigatsubo Y, Tani K, Okubo T, OkudaK (1997): Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1- specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. 27, 782-787.
20. Yang G, Hellstrom KE, Hellstrom I, Chen L (1995): Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 co-stimulatory molecules. J. Immunol. 154, 2794-2800.